UCB's Global Corporate Website

This section is intended for media and financial analysts

Search Press releases

8 Jan 2018

CIMZIA® (certolizumab pegol) label change marks important advance for European women of childbearing age with chronic rheumatic disease

Read More
8 Jan 2018

European Medicines Agency Accepts Filing for EVENITY™ (romosozumab) 

Read More
19 Dec 2017

Bimekizumab demonstrates impressive joint and skin responses for psoriatic arthritis patients 

Read More
13 Dec 2017

Bimekizumab advances with significant results in ankylosing spondylitis patients

Read More
30 Nov 2017

UCB showcases new research and continued epilepsy leadership at the 2017 American Epilepsy Society Annual Meeting

Read More
7 Nov 2017

New study data shows prior osteoporotic fractures put women at increased risk of future major osteoporotic fractures

Read More

Stay up-to-date on the latest news and information from UCB